Test Strip Access Act of 2025

Bill Number

H.R. 1562

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-02-25: Referred to the House Committee on Energy and Commerce.

Last Updated

2025-05-05T12:48:22Z

AI-Generated Summary

Purpose

The Test Strip Access Act of 2025 aims to expand access to tools for preventing substance use disorders and overdoses by explicitly allowing federal grants to fund test strips for detecting fentanyl and xylazine—two substances often mixed with other drugs that increase overdose risks. This builds on efforts to combat the opioid crisis by clarifying how existing grant funds can be used.

Key Provisions

• Amendment to Existing Law: The bill modifies Section 1003(b)(4)(A) of the 21st Century Cures Act (a 2016 law focused on health innovation and mental health support).
• Grant Authorization: It permits states and tribal governments receiving grants under the State and Tribal Opioid Response program to use funds for "fentanyl or xylazine test strips" in overdose prevention activities.
• Scope: These test strips are added alongside other approved drugs or devices under the Federal Food, Drug, and Cosmetic Act (a key U.S. law regulating food, drugs, and medical devices).

Significant Changes to Existing Law

• Previously, the 21st Century Cures Act allowed grants for certain prevention tools but did not explicitly mention test strips for fentanyl or xylazine, potentially creating uncertainty about their eligibility.
• The amendment inserts specific language to make these test strips clearly fundable, removing any ambiguity and broadening the types of prevention activities supported without requiring new funding.

Potential Impacts

• On Government Agencies: The Department of Health and Human Services (which oversees these grants) could see streamlined grant administration, as recipients gain clearer guidance on allowable uses, potentially increasing program efficiency.
• On Citizens: Individuals at risk of opioid overdoses, particularly those using illicit drugs, may benefit from wider availability of affordable test strips, helping them detect dangerous contaminants and reduce harm—ultimately lowering overdose deaths.
• On International Relations: Minimal direct impact, though it indirectly supports U.S. public health efforts amid a global opioid crisis involving cross-border drug trafficking.

Main Stakeholders Affected

• States and Tribal Governments: Primary recipients of the grants, enabling them to implement local prevention programs more effectively.
• Public Health Organizations and Providers: Groups distributing harm reduction tools, such as needle exchanges or community health centers, who can now access federal support for test strips.
• Individuals with Substance Use Disorders: End-users who gain better tools for safer drug use, potentially saving lives.
• Federal Agencies: Like the Substance Abuse and Mental Health Services Administration (SAMHSA), which manages the grants and may need to update guidelines.

Notable Legal, Constitutional, or Political Implications

• Legal: Strengthens the framework of the 21st Century Cures Act by clarifying grant uses, reducing potential legal challenges over fund allocation without altering broader regulatory structures. No conflicts with constitutional principles, as it involves standard congressional authority over federal spending.
• Constitutional: Aligns with Congress's power to appropriate funds for public health (under Article I), promoting welfare without infringing on individual rights.
• Political: Bipartisan introduction (by Rep. Crockett and Rep. Gooden) signals broad support for harm reduction in the opioid crisis; if passed, it could encourage similar expansions in drug policy without sparking major controversy, as it focuses on prevention rather than enforcement.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Crockett, Jasmine [D-TX-30]

Cosponsors (1)

Rep. Gooden, Lance [R-TX-5]

Recent Actions

• 2025-02-25: Referred to the House Committee on Energy and Commerce.
• 2025-02-25: Introduced in House
• 2025-02-25: Introduced in House

Bill Versions

• Test Strip Access Act of 2025 — issued 2025-02-25 — PDF (2 pages)